Publications, Gunnar Carlin1
1.Carlin G, Arfors K-E, Saldeen T, Tangen O: On the formation and lysis of fibrin. Forensic Science 7: 87-88, 1976.
Abstract.
2.Carlin G, Wik K-O, Arfors K-E, Saldeen T, Tangen O: On the formation and structure of fibrin. Thrombosis Research 9: 623-636, 1976.
3.Carlin G, Arfors K-E, Saldeen T, Tangen O, Wik K-O: Influences on the formation structure and lysis of fibrin. Proceedings of the 6th Scandinavian Meeting in Forensic Medicine, Helsinki, June 16-18, 1976, p 84-86.
4.Carlin G, Arfors K-E, Saldeen T, Tangen O, Wik K-O: Influences on the formation, structure and lysis of fibrin. 6th Scandinavian Meeting in Forensic Medicine, Helsinki, June 16-18. Forensic Science 8: 178, 1976.
Abstract.
5.Carlin G, Swahn U: De svenska Usnea-arterna (skägglavar). Svensk Bot. Tidskr. 71:89-100, 1977.
6.Carlin G, Saldeen T: Effect of dextran on the activity of plasminogen-plasmin inhibitors in the blood. 9th Meeting of the Swedish Society for Forensic Medicine, Stockholm, Dec 3, 1976. Forensic Science 10: 157-158, 1977.
Abstract.
7.Sandler H, Arfors K-E, Carlin G, Saldeen T: Microscopy of microembolism in vivo. 9th Meeting of the Swedish Society for Forensic Medicine, Stockholm, Dec 3, 1976. Forensic Science 10: 159-160, 1977.
Abstract.
8.Carlin G, Saldeen T: Influence of dextran 70 on the action of the primary fibrinolysis inhibitor 2-plasmin inhibitor. Thrombosis Research 12: 681-686, 1978.
9.Carlin G, Saldeen T: Effect of dextran on fibrinolysis inhibition activity in serum. Thrombosis Research 12: 1165-1175, 1978.
10.Carlin G, Saldeen T: Effect of dextran on the primary fibrinolysis inhibitor (2-plasmin inhibitor). 4th International Conference on Synthetic Fibrinolytic-thrombolytic Agents. Karlovy Vary, Sept. 5-8, 1978, p 34.
Abstract.
11.Carlin G, Saldeen T: Effect of dextran on the primary fibrinolysis inhibitor (2-plasmin inhibitor). Progress in Chemical Fibrinolysis and Thrombolysis 4, Ed: JF Davidson, Edinburgh: Churchill Livingstone, 1979, pp 54-60.
12.Carlin G, Modig J, Saldeen T: Effect of infusion of dextran 70 on fibrinolysis inhibition activity of serum in man. Acta Chir Scand 145: 129-131, 1979.
13.Carlin G: On dextran and the fibrinolytic inhibition of serum. The Microembolism Syndrome, Ed: T Saldeen, Stockholm: Almqvist, Wiksell Int., 1979, pp 169-178.
14.Carlin G, Karlström G, Modig J, Saldeen T: Effect of dextran on posttraumatic fibrinolysis inhibition. VIIth International Congress on Thrombosis and Haemostasis. London 1979. Thrombosis Haemostasis 42: 320, 1979.
Abstract.
15.Bagge L, Carlin G, Hjelmstedt E, Högstorp H, Jakobsson H, Modig J, Saldeen T: Fibrinolysis inhibition after a standardized trauma, total hip replacement surgery. VIIth International Congress on Thrombosis and Haemostasis. London 1979. Thrombosis Haremostasis 42: 278, 1979.
Abstract.
16.Carlin G, Karlström G, Modig J, Saldeen T: Effect of dextran on fibrinolysis inhibition activity in blood after major surgery. Acta Anaesthes Scand 24: 375-378, 1980.
17.Carlin G, Karlström G, Modig J, Saldeen T: Dextran och fibrinolyshämning. Läkarstämman, Stockholm 1979. Acta Soc Med Suecanae Hygiea 88: 570, 1979.
Abstract.
18.Carlin G: Urokinase-induced fibrin clot lysis, and its inhibition by plasma. Upsala J Med Sci 85: 29-33, 1980.
19.Carlin G, Bang NU, Saldeen T: Effect of dextran on plasma clot lysis. 5th International Conference on Fibrinolytic Thrombolytic Agents, Malmö, June 17-20, 1980.
Abstract.
20.Carlin G, Bang NU: Enhancement of plasminogen activation and purified fibrin clot lysis by dextran 70. Thrombosis Research 19: 535-546, 1980.
21.Carlin G, Saldeen T: On the interaction between dextran and the primary fibrinolysis inhibitor 2-antiplasmin. Thromobsis Research 19: 103-110, 1980.
22.Carlin G: Effect of dextran on fibrinolysis. Acta Univ Ups. Abstracts of Upsala Dissertations from the Faculty of Medicine 365, Uppsala 1980. Dissertation.
23.Carlin G, Bang NU, Saldeen T: Effect of dextran on plasma clot lysis. Progress in Fibrinolysis 5; Ed J Davidson et al., Edinburgh: Churchill Livingstone, 1981, pp 331-335.
24.Högstorp H, Jacobsson H, Carlin G: Studies on 2-antiplasmin in the rat. Thrombosis Research 21: 247-253, 1981.
25.Carlin G, Einarsson M, Saldeen T: Delayed elimination of fibrin from the lungs in rats treated with the primary fibrinolysis inhibitor 2-antiplasmin. VIII International Congress on Thrombosis and Haemostasis, Toronto, 1981. Thrombosis Haemostasis 46: 281, 1981.
Abstract.
26.Carlin G, Einarsson M, Saldeen T: Delayed elimination of fibrin from the lungs in rats treated with the primary fibrinolysis inhibitor 2-antiplasmin. Thrombosis Haemostasis 46:757-758, 1981.
27.Sprung C, Carlin G, Ryan J, Saldeen T: Proteinbestämning i ödemvätska från patienter med lungödem. Läkarstämman, Stockholm, 1981. Acta Soc Med Suecanae Hygiea 90: 499, 1981.
Abstract.
28.Jacobsson H, Carlin G, Saldeen T: Posttraumatiska förändringar i histidin-rikt glykoprotein - av betydelse för fibrinolysen? Läkarstämman, Stockholm, 1981. Acta Soc Med Suecanae Hygiea 90: 499, 1981.
Abstract.
29.Carlin G, Ryan JW, Saldeen T: Assays for enzymes of the kallikrein-kinin system using first order reaction kinetics. KININ 1981. International Conference on Kallikreins, Kinins, Kininogens, Kininases, München, Nov 2-5, 1981.
Abstract.
30.Ryan JW, Carlin G, Berryer P, Chung A: Potentiation of bradykinin by inhibitors of angiotensin converting enzyme. KININ 1981. International Conference on Kallikreins, Kinins, Kininogens, Kininases, München, Nov 2-5, 1981.
Abstract.
31.Carlin G: De svenska bägarlavarna (Cladonia undersläktet Cladonia). Svensk Bot. Tidskr. 75:361-391, 1981.
32.Jacobsson H, Carlin G, Saldeen T: Histidine-rich glucoprotein - of importance for posttraumatic fibrinolysis inhibition? 6th international Congress on Fibrinolysis, Lausanne, July 20-23, 1982. Haemostasis 11, Suppl 1: 50, 1982.
Abstract.
33.Carlin G, Einarsson M, Saldeen T: Tissue plasminogen activator effectively lyses intravascular fibrin deposits in the rat lung. 6th international Congress on Fibrinolysis, Lausanne, July 20-23, 1982. Haemostasis 11, Suppl 1: 77, 1982.
Abstract.
34.Carlin G, Saldeen T: Studies on posttraumatic fibrinolysis inhibition by use of tissue plasminogen activator. 6th international Congress on Fibrinolysis, Lausanne, July 20-23, 1982. Haemostasis 11, Suppl 1: 85, 1982.
Abstract.
35.Carlin G, Santerre RF, Bang NU, Broadie TA: Human mesothelial cells in culture synthesize prostacyclin. Central Society for Clinical Research meeting, Chicago, Nov 5, 1982. Clinical Res 30: 771A, 1982.
Abstract.
36.Bagge L, Carlin G, Hjelmstedt E, Högstorp H, Jakobsson H, Modig J, Saldeen T: Fibrinolysis inhibition after a major standardized trauma. Upsala J Med Sci 87: 55-66, 1982.
37.Carlin G, Carlin-Silväng U: De svenska Stereocaulon-arterna (påskrislavar). Svensk Bot. Tidskr. 76:289-307, 1982.
38.Carlin G, Ryan JW, Saldeen T: Assays of components of the kallikrein-kinin system based on first order reactin kinetics. Advances in Experimental Medicine and Biology 156, Ed H Fritz et al, New York: Plenum Press, 1983, pp 797-804.
39.Ryan JW, Carlin G, Berryer P, Chung A: Potentiation of bradykinin by inhibitors of angiotensin converting enzyme. Advances in Experimental Medicine and Biology 156, Ed H Fritz et al, New York: Plenum Press, 1983, pp 613-620.
40.Saldeen T, Carlin G, Einarsson M: Effektiv lys av mikroembolier i lungorna hos råtta med hjälp av plasminogenaktivator. Läkarstämman, Stockholm, 1982. Acta Soc Med Suecanae Hygiea 91: 248, 1982.
Abstract.
41.Jacobsson H, Carlin G, Saldeen T: Histidine-rich glucoprotein - of importance for posttraumatic fibrinolysis inhibition? Progress in Fibrinolysis 6: Ed. JF Davidson et al, Edinburgh: Churchill Livingstone, 1983, pp 408-411.
42.Carlin G, Einarsson M, Saldeen T: Tissue plasminogen activator effectively lyses intravascular fibrin deposits in the rat lung. Progress in Fibrinolysis 6: Ed. JF Davidson et al, Edinburgh: Churchill Livingstone, 1983, pp 471-474.
43.Carlin G, Allison P, Bang NU: The effect of plasminogen activators on fibrin crosslinking. IXth international Congress on Thrombosis and Haemostasis, Stockholm, July 3-8, 1983 Thrombosis Haemostasis 50: 145, 1983.
Abstract.
44.Carlin G, Santerre RF, Bang NU: Functional properties of human mesothelial cells in culture. IXth international Congress on Thrombosis and Haemostasis, Stockholm, July 3-8, 1983. Thrombosis Haemostasis50: 145, 1983.
Abstract.
45.Carlin G, Bang NU: Fibrin stimulates the elaboartion of monocyte procoagulant and proteolytic activities. IXth international Congress on Thrombosis and Haemostasis, Stockholm, July 3-8, 1983. Thrombosis Haemostasis 50: 17, 1983.
Abstract.
46.Carlin G, Bang NU: Fibrin stimulates the elaboration of monocyte procoagulant and proteolytic activities. Central Society for Clinical Research, Nov 4 1983, Chicago. Clinical Res 31: 768A, 1983.
Abstract.
47.Carlin G, Djursäter R, Smedegård G, Gerdin B: The effect of some antirheumatic drugs on the free radical mediated hyalyronic acid degradation and xanthine oxidase activity. 1st World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators, Venice, April 16-18 1984.
Abstract.
48.Carlin G, Djursäter R: Xanthine oxidase induced depoymerization of hyaluronic acid in the presence of ferritin. FEBS Letters 177: 27-30, 1984.
49.Saldeen P, Carlin G, Saldeen T: In vitro synthesis of thromboxane A2 and prostacyclin. 7th International Congress on Thrombosis, Valencia, Oct 13-16, 1982. Haemostasis 12: 56, 1984.
Abstract.
50.Carlin G, Wibell L, Saldeen T: Production of thromboplastin and elastase in monocytes from patients with deep venous thrombosis (DVT). 7th International Congress on Fibrinolysis, Venice, March 27-30, 1984. Haemostasis 14: 28, 1984.
Abstract.
51.Carlin G, Djursäter R, Smedegård G, Gerdin B: Effect of antiinflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid. Agents and Actions 16: 377-384, 1985.
52.Rosengren S, Carlin G, Smedegård G: Vascular leakage induced by xanthine oxidase in rat skin - an oxygen mediated reaction? 15th annual meeting of the Nordic Microcirculatory Society. Geilo, Feb 7-9 1985. Int J Microcirc: Clin Exp 4: 211, 1985.
Abstract.
53.Rosengren S, Carlin G, Smedegård G: Xanthine oxidase induced vascular leakage in rat skin. XVII Nordic congress for physiology and pharmacology, Uppsala, June 10-13, 1985. Acta Physiol Scand 124: Suppl 542: 413, 1985.
Abstract.
54.Carlin G, Djursäter R, Gerdin B: SOD-like activity of copper-histidine. XVII Nordic congress for physiology and pharmacology, Uppsala, June 10-13, 1985. Acta Physiol Scand 124: Suppl 542: 414, 1985.
Abstract.
55.Gerdin B, Carlin G, Djursäter R: SOD-like activity of Copper-Histidine. Fourth international conference on superoxide and superoxide dismutase. Rome, Sept 1985.
Abstract.
56.Carlin G: Stereocaulon capitellatum i Skandinavien. Svensk Bot. Tidskr. 79:49-50, 1985.
57.Carlin G, Arfors K-E: Lipid peroxidation promoted by human polymorphonuclear leucocytes. Fourth international conference on superoxide and superoxide dismutase. Rome, Sept 1985.
Abstract.
58.Carlin G, Djursäter R, Goldschmidt T, Smedegård G, Arfors K-E Degradation of hyaluronic acid and collagen by oxygen derived radicals. Inflammation. Basic Mechanisms, Tissue Injuring Principles, and Clinical Models. Eds P Venge & A Lindbom. Stockholm: Almqvist & Wiksell Int. 1985, pp 297-301.
59.Carlin G, Arfors K-E: Lipid peroxidation promoted by human polymorphonuclear leucocytes. Society For Free Radical Research, Winter Meeting, London, Dec 1985.
Abstract.
60.Carlin G: Peroxidation of linolenic acid promoted by human polymorphonuclear leucocytes and xanthine oxidase. J Free Rad Biol Med 1: 255-261, 1986.
61.Carlin G, Arfors K-E: Lipid peroxidation promoted by human polymorphonuclear leucocytes. In: Superoxide and superoxide dismutase in chemistry, biology and medicine. Ed: G. Rotilio. Elsevier Science Publishers, Amsterdam 1986, pp 22-24.
62.Gerdin B, Carlin G, Djursäter R: SOD-like activity of Copper-Histidine. In: Superoxide and superoxide dismutase in chemistry, biology and medicine. Ed: G. Rotilio. Elsevier Science Publishers, Amsterdam 1986, pp 69-71.
63.Carlin G, Arfors K-E: Peroxidation of liposomes promoted by human polymorphonuclear leucocytes. J Free Rad Biol Med 1:437-442, 1986 (1985).
64.Carlin G, Smedegård G, Åhman H: Inhibition of neutrophil superoxide production by sulphasalazine and indomethacin Society For Free Radical Research, Winter Meeting, London, Dec 1986.
Abstract.
65.Carlin G, Smedegård G, Åhman H: Effects of sulfasalazine, azodisalicylic acid and indomethacin on superoxide secretion by polymorphonuclear leukocytes. European Society for Clinical Investigation 21st Annual Scientific Meeting, Elsinore 21-24 March 1987. Eur J Clin Invest 17: A65, 1987.
Abstract.
66.Carlin G, Smedegård G, Åhman H: Effect of Sulfasalazine and indomethacin on superoxide secretion by PMN leukocytes (PMNLs). XIth European Congress of Rheumatology. 28th June - 4th July 1987 Athens, Greece. Clin Exper Rheum 5: Suppl 2: 236, 1987.
Abstract.
67.Carlin G: The chemical strains of Usnea lapponica and U. glabrescens in Sweden. Graphis Scripta 1:29-32, 1987.
68.Carlin G: On the use of chemical characters in lichen taxonomy. Graphis Scripta 1:72-76, 1987.
69.Högstorp H, Carlin G: Two forms of 2-antiplasmin: posttraumatic changes in the rat. Upsala J Med Sci 92: 79-83, 1987.
70.Carlin G, Djursäter R: Peroxidation of phospholipids promoted by myeloperoxidase. Society For Free Radical Research, Winter Meeting, London, Dec 1987.
Abstract.
71.Carlin G, Djursäter R: Peroxidation of phospholipids promoted by myeloperoxidase. Free Rad Res Commun4: 251-257, 1988.
72.Sönnerborg A, Carlin G, Åkerlund B, Jarstrand C: Increased production of malondialdehyde in patients with human immunodeficiency virus infection Scand J Infect Dis 20: 287-290, 1988.
73.Högstorp H, Carlin G: Studies on biosynthesis of 2-antiplasmin in rat liver cells. Thrombosis Res49: 307-318, 1988.
74.Carlin G, Djursäter R, Arfors K-E: Inhibition of heme-promoted lipid peroxidation by desferrioxamine and EDTA. Upsala J Med Sci 93: 215-223, 1988.
75.Jarstrand C, Carlin G, Sönnerborg A, Åkerlund B: Nitroblue tetrazolium (NBT) reduction by neutrophils and malondialdehyde production in patients with HIV-infection. IV International Conference on AIDS, Stockholm, June 12-16, 1988.
Abstract.
76.Carlin G, Åhman H, Djursäter R, Smedegård G: Inhibition of leukocyte superoxide production by sulfasalazine. Medical, biochemical and chemical aspects of free radicals. Proceedings of the 4th biennial general meeting of the Society for Free Radical Research, Kyoto, April 9-13, 1988. Eds: Hayaishi O, Niki E, Kondo M & Yoshikawa T. Elsevier Science Publishers 1989, pp 511-514.
77.Carlin G, Djursäter R: Effect of sulfasalazine on human granulocyte phosphatidylinositol (PI) and phosphatidylinositol-4-phosphate (PIP) kinases. 3rd Interscience World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators, Monte Carlo, March 15-18, 1989.
Abstract.
78.Carlin G, Djursäter R, Smedegård G: Inhibitory effects of sulfasalazine and related compounds on superoxide secretion by human polymorphonuclear leukocytes. Pharmacol Toxicol 64: 121-127, 1989.
79.Nilsson UA, Olsson LI, Carlin G, Bylund-Fellenius AC: Inhibition of lipid peroxidation by spin labels - Relationships between structure and function. J Biol Chem 264: 11131-11135, 1989.
80.Hallewell RA, Laria I, Tabrizini A, Carlin G, Getzoff ED, Tainer JA, Cousens LS, Mullenbach GT: Genetically engineered polymers of human CuZn superoxide-dismutase - Biochemistry and serum half-lives. J Biol Chem 264:5260-5268, 1989.
81.Nilsson UA, Carlin G, Bylund-Fellenius AC: The hydroxylamine OXANOH and its reaction product, the nitroxide OXANO¨, act as complementary inhibitors of lipid peroxidation. Chem biol Interact 74:325-342, 1990.
82.Carlin G, Djursäter R, Smedegård G: Effects of sulfasalazine on human granulocyte signal transduction. Hungarian Rheumatology 32: 1991Suppl. p. 228. 12th European Congress ofRheumatology, Budapest, June 30 - July 6, 1991.
Abstract.
83.Løvaas E, Carlin G: Spermine: An antioxidant and anti-inflammatory agent. Free Rad Biol Med 11: 455-461, 1991.
84.Carlin G: Anteckningar om några arter av Peltigera canina-gruppen i Sverige. Graphis Scripta 4: 5-17, 1992.
85.Carlin G, Djursäter R, Smedegård G: Effects of sulfasalazine on human granulocyte signal transduction. Scandinavian Journal of Rheumatology Supplement 93: 70. 24th Scandinavian Congress ofRheumatology, Malmö, May 31 - June 3, 1992
Abstract.
86.Carlin G, Djursäter R, Smedegård G: Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds. Ann Rheum Dis 51: 1230-1236, 1992.
87.Carlin G, Djursäter R, Smedegård G: Sulfasalazine inhibits leukocyte signal transduction. XVIIIth ILAR Congress of Rheumatology. Barcelona, July 4 - 10, 1993. Revista Española de Reumatologia 20 Suppl. 1: 184, 1993.
Abstract.
88.Carlin G, Djursäter R, Smedegård G: Sulfasalazine inhibits leukocyte signal transduction. IAIS World Congress Inflammation '93. Wien, October 10 - 15, 1993.
Abstract.
89.Carlin G, Owe-Larsson B: Cladonia polycarpoides in Sweden, with a note on C. cervicornis ssp. pulvinata. Graphis Scripta 6: 1-6, 1994.
90.Carlin G: Sulfasalazine does not inhibit cyclooxygenases 1 and 2. American College of Rheumatology, 58th National Scientific Meeting. Minneapolis, October 23 - 24, 1994. Arthritis and Rheumatism 37 (Supplement 9):S 383, 1994.
Abstract.
91.Carlin G, Nyman AK, Grönberg A: Effects of sulfasalazine on cytokine production by mitogen-stimulated human T-cells. American College of Rheumatology, 58th National Scientific Meeting. Minneapolis, October 23 - 24, 1994. Arthritis and Rheumatism 37 (9, Supplement):S 383, 1994.
Abstract.
92.Cronstein BN, Gadangi P, Longaker M, Naime D, Carlin G: Adenosine mediates the antiinflammatory effects of sulfasalazine (ssa) both in vitro and in vivo. American Federation for Clinical Research. San Diego, May 5 - 8, 1995.
Abstract.
93.Carlin G, M. Jidenius: Sulfasalazine inhibits substance P induced granulocyte activation. IAIS Second World Congress Inflammation '95. Brighton, September 17 - 22, 1995. Inflammation Research 44 (Supplement 3): S 285, 1995.
Abstract.
94.Gadangi P, Longaker M, Naime D, Carlin G, Cronstein BN: The antiinflammatory action of sulfasalazine (ssa) is mediated by adenosine (ADO). American College of Rheumatology, 59th National Scientific Meeting. San Francisco, October 22 - 26, 1995. Arthritis and Rheumatism 38 (9, Supplement):S371, 1995.
Abstract.
95.Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, Buckley MT, Carlin G, Cronstein BN: The antiinflammatory action of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 156:1937-1941, 1996.
96.Lundberg C, Åsberg I, Carlin G, Berglindh T: 5-aminosalicylic acid (5-ASA) induced nephrotoxicity is dose dependent in rats. International Inflammatory Bowel Disease Meeting. Chester College, April 15-16, 1996. Gut XX: A635, 1996.
Abstract.
97.Moberg R, Carlin G: The genus Placopsis (Trapeliaceae) in Norden. Symb Bot Ups 31:319-325, 1996.
98.Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson LF, Resta R, Carlin G, Huie MA, Cronstein BN: Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101:295-300, 1998.
99.Carlin G: Stereocaulon tennesseense new to Sweden. Graphis Scripta 9: 33-34, 1998.
100.Carlin G: Chemistry. In: Ahti T, Jörgensen P M, Kristiansson H, Moberg R, Söchting U, Thor G (eds): Nordic Lichen Flora I. 1999.
101.Carlin G, Viitanen E: Measurement of TNF-α activity by flow cytometry. Annual OMCL meeting. Hillerød, 11-13 October 1999.
Abstract
102.Moberg R, Carlin G: Placopsis lambii, new to Africa. Lichenologist 31:647-648, 1999.
103.Hartung T, Aaberge I, Berthold S, Carlin G, Charton E, Coecke S, Fennrich S, Fischer M, Gommer M, Halder M, Haslov K, Jahnke M, Montag-Lessing T, Poole S, Schechtman L, Wendel A, Werner-Felmayer G. Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods. European Centre for the Validation of Alternative Methods. Altern Lab Anim. 29: 99-123, 2001.
104.Carlin G. M. Inglis, Field Guide to the Deep Sky Objects, Springer-Verlag, Berlin/Heidelberg. Populär astronomi 3(2): 33, 2001
Recension.
105.Carlin G. Sjärnhimlen. (Kvartalskrönika).Telescopium 8-13: 2001-2006.
106.Carlin G. Mars kommer extremt nära jorden 2003. (OBS publikationsdatum! publicerad innan detta faktum var allmänt känt) Telescopium 9(1):9, 2002.
107.Carlin G. Percival Lowell 1855-1916. Telescopium 10(2): 7-8, 2003.
108.Carlin G, Viitanen E. In vitro pyrogenicity of a multivalent vaccine: Infanrix. Pharmeuropa. 15: 418-423, 2003.
109.Carlin G. Halley och Venuspassagen. Telescopium 11(3): 9-10, 2003.
110.Strandell J, Neil A, Carlin G. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine. 11: 98-104, 2004.
111.Carlin G. Venuspassager. Telescopium 11(1): 11-12, 2004.
112.Carlin G, Viitanen E.In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussiscomponents of a trivalent vaccine.Vaccine. 23: 3709-3715, 2005.
113.Carlin G.Konsten att beräkna påskdagen. Telescopium 2008 (1), p.16-20.
114.Carlin G. Konsten att beräkna påskdagen (fortsättning). Telescopium2008 (2), p. 16-20.
115.McEwen I, Rundlöf T, Ek M, Hakkarainen B, Carlin G, Arvidsson T. Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin. J. Pharm. Biomed. Anal. 49: 816-819, 2009.
116.Kühler TC, Andersson M, Carlin G, Johnsson A, Åkerblom L. Do biological medicinal products pose a risk to the environmentA current view on ecopharmacovigilance.Drug Safetyaccepted 2009.